コンテンツへスキップ
Merck
  • CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis.

CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis.

Journal of immunology (Baltimore, Md. : 1950) (2004-11-24)
Traci L Ness, Kristin J Carpenter, Jillian L Ewing, Craig J Gerard, Cory M Hogaboam, Steven L Kunkel
要旨

CCR1 has previously been shown to play important roles in leukocyte trafficking, pathogen clearance, and the type 1/type 2 cytokine balance, although very little is known about its role in the host response during sepsis. In a cecal ligation and puncture model of septic peritonitis, CCR1-deficient (CCR1(-/-)) mice were significantly protected from the lethal effects of sepsis when compared with wild-type (WT) controls. The peritoneal and systemic cytokine profile in CCR1(-/-) mice was characterized by a robust, but short-lived and regulated antibacterial response. CCR1 expression was not required for leukocyte recruitment, suggesting critical differences extant in the activation of WT and CCR1(-/-) resident or recruited peritoneal cells during sepsis. Peritoneal macrophages isolated from naive CCR1(-/-) mice clearly demonstrated enhanced cytokine/chemokine generation and antibacterial responses compared with similarly treated WT macrophages. CCR1 and CCL5 interactions markedly altered the inflammatory response in vivo and in vitro. Administration of CCL5 increased sepsis-induced lethality in WT mice, whereas neutralization of CCL5 improved survival. CCL5 acted in a CCR1-dependent manner to augment production of IFN-gamma and MIP-2 to damaging levels. These data illustrate that the interaction between CCR1 and CCL5 modulates the innate immune response during sepsis, and both represent potential targets for therapeutic intervention.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
スルファニルアミド, puriss. p.a., ≥98% (calc. to the dried substance)